PALO ALTO, CALIF.--(Business Wire / Korea Newswire)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the U.S. Food and Drug Administration (FDA) has approved the company’s Shield™ blood test for colorectal...